Table 1

Prognostic clinicopathological variables as predictors for disease-specific survival soft tissue sarcomas (univariate analysis, log rank test), N = 249
Characteristic Patients (n) Patients (%) Median survival (months) 5-Year survival (%) P
Age
 ≤ 20 years 20 8 15 40 0.126
 21-60 years 113 45 68 52
 > 60 years 116 47 30 40
Gender
 Male 110 44 41 46 0.390
 Female 139 56 45 45
Nationality
 Norwegian 167 67 63 51 0.011
 Russian 82 33 22 34
Histology

 Undifferentiated

 pleomorphic sarcoma

68 27 29 40 0.102
 Leiomyosarcoma 67 27 45 46
 Liposarcoma 34 14 NR 67
 MF/MFT 20 8 43 50
 Angiosarcoma 13 5 10 31
 Rhabdomyosarcoma 16 6 17 38
 MPNST 11 4 49 45
 Synovial sarcoma 16 6 31 29
 Other STS 4 2 NR 75
Tumor localization
 Extremities 89 36 100 53 0.348
 Trunk 47 29 32 44
 Retroperitoneum 37 25 25 38
 Head/Neck 18 7 15 41
 Visceral 58 23 30 42
Tumor size
 < 5 cm 74 30 127 57 0.027
 5-10 cm 91 37 44 45
 > 10 cm 81 32 28 37
 Missing 3 1
Malignancy grade FNCLCC
 1 61 25 NR 74 <0.001
 2 98 39 41 45
 3 90 36 16 26
Tumor depth
 Superficial 17 7 NR 93 <0.001
 Deep 232 93 36 42
Metastasis at time of diagnosis
 No 206 83 76 53 <0.001
 Yes 43 17 10 10
Surgery
 Yes 228 92 59 50 <0.001
 No 21 8 5 0
Surgical margins
 Wide 108 43 NR 62 <0.001
 Non-wide 141 57 19 33
Chemotherapy
 No 191 77 52 47 0.424
 Yes 58 23 29 40
Radiotherapy
 No 176 71 48 46 0.590
 Yes 73 29 38 43

Abbreviations: MF/MFT, malignant fibroblastic/myofibroblastic tumors; MPNST, malignant peripheral nerve sheath tumor; STS, soft tissue sarcomas; NR, not reached; NOS, non specified.

Sorbye et al.

Sorbye et al. BMC Clinical Pathology 2012 12:7   doi:10.1186/1472-6890-12-7

Open Data